Table 1

 Subject characteristics and clinical measures at study commencement for CF and control participants divided into two age groups: children (5–10 years) and adolescents (11–18 years)

CFControlp value
NMean (SD)NMean (SD)
Values are mean (SD) unless otherwise stated.
BMD, bone mineral density; FEV1, forced expiratory volume in 1 second.
Children
    F/M4021/193218/140.81
    Age (years)408.5 (1.8)328.5 (1.5)0.89
    Weight Z-score400.02 (0.97)320.28 (1.09)0.28
    Height Z-score40−0.22 (0.95)320.21 (1.06)0.10
    Total body BMD Z-score400.23 (0.74)320.26 (0.70)0.87
    Lumbar spine BMD Z-score40−0.28 (0.95)32−0.31 (0.99)0.88
    FEV1 (%) median (range)3984 (46–116)
    FVC (%) median (range)3993 (53–122)
Adolescents
    N (F/M)4518/276836/320.19
    Age (years)4514.1 (2.2)6813.9 (1.9)0.47
    Weight Z-score45−0.75 (0.91)680.26 (0.82)<0.001
    Height Z-score45−0.87 (0.84)680.59 (0.97)<0.001
    Total body BMD Z-score45−1.29 (1.48)680.37 (0.93)<0.001
    Lumbar spine BMD Z-score45−0.53 (1.22)68−0.18 (1.24)<0.001
    FEV1 (%) median (range)4586 (23–124)
    FVC (%) median (range)4590 (36–123)